Systematic mapping of rRNA 2'-O methylation during frog development and involvement of the methyltransferase Fibrillarin in eye and craniofacial development in Xenopus laevis

PLoS Genet. 2022 Jan 18;18(1):e1010012. doi: 10.1371/journal.pgen.1010012. eCollection 2022 Jan.

Abstract

Ribosomes are essential nanomachines responsible for protein production. Although ribosomes are present in every living cell, ribosome biogenesis dysfunction diseases, called ribosomopathies, impact particular tissues specifically. Here, we evaluate the importance of the box C/D snoRNA-associated ribosomal RNA methyltransferase fibrillarin (Fbl) in the early embryonic development of Xenopus laevis. We report that in developing embryos, the neural plate, neural crest cells (NCCs), and NCC derivatives are rich in fbl transcripts. Fbl knockdown leads to striking morphological defects affecting the eyes and craniofacial skeleton, due to lack of NCC survival caused by massive p53-dependent apoptosis. Fbl is required for efficient pre-rRNA processing and 18S rRNA production, which explains the early developmental defects. Using RiboMethSeq, we systematically reinvestigated ribosomal RNA 2'-O methylation in X. laevis, confirming all 89 previously mapped sites and identifying 15 novel putative positions in 18S and 28S rRNA. Twenty-three positions, including 10 of the new ones, were validated orthogonally by low dNTP primer extension. Bioinformatic screening of the X. laevis transcriptome revealed candidate box C/D snoRNAs for all methylated positions. Mapping of 2'-O methylation at six developmental stages in individual embryos indicated a trend towards reduced methylation at specific positions during development. We conclude that fibrillarin knockdown in early Xenopus embryos causes reduced production of functional ribosomal subunits, thus impairing NCC formation and migration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromosomal Proteins, Non-Histone / genetics*
  • Chromosomal Proteins, Non-Histone / metabolism*
  • Eye / growth & development
  • Eye / metabolism
  • Gene Knockdown Techniques
  • Methylation
  • Neural Crest / growth & development
  • Neural Crest / metabolism
  • Neural Plate / growth & development
  • Neural Plate / metabolism
  • RNA Precursors / metabolism*
  • RNA Processing, Post-Transcriptional
  • RNA, Ribosomal, 18S / metabolism*
  • RNA, Ribosomal, 28S / metabolism*
  • Xenopus Proteins / genetics
  • Xenopus Proteins / metabolism
  • Xenopus laevis / genetics
  • Xenopus laevis / growth & development*

Substances

  • Chromosomal Proteins, Non-Histone
  • RNA Precursors
  • RNA, Ribosomal, 18S
  • RNA, Ribosomal, 28S
  • Xenopus Proteins
  • fibrillarin

Grants and funding

JD and RL were recipients of a FRIA PhD fellowship (F.R.S./FNRS, https://www.frs-fnrs.be/en/). LT was the recipient of a ‘Chargé de Recherches’ fellowship from the Fonds de la Recherche Scientifique (F.R.S./FNRS). Research in the Lafontaine laboratory is supported by the Belgian Fonds de la Recherche Scientifique (F.R.S./FNRS, PDR grant n°T.0144.20), the European Joint Programmes on Rare Diseases (EJP RD/JTC2019/PINT-MULTI) ‘RiboEurope’ and ‘DBAGeneCure’ (grant n°R.8015.19 and n°R.8011.20), the Université libre de Bruxelles (ULB https://www.ulb.be/en/ulb-homepage), the Région Wallonne (SPW EER https://www.wallonie.be/fr/acteurs-et-institutions/wallonie/spw-economie-emploi-recherche/departement-de-la-recherche-et-du-developpement-technologique#) (‘RIBOcancer’ FSO grant n°1810070 and POC n°1880014), the Fonds Jean Brachet, the Internationale Brachet Stiftung, and the Epitran COST action (CA16120 https://epitran.eu/). YM was supported by FRCR EpiARN project from Grand Est Region, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.